Rheumatology
Hypermobile Ehlers-Danlos Syndrome (hEDS)

( Previously known as Joint Hypermobility Syndrome (JHS) and Ehlers-Danlos Type III (EDS-III) )

Professor Jaime F. Bravo , MD

DOCTOR BRAVO IS ONLY SEEING PATIENTS ONLINE,

TO ASK FOR AN APPOINTMENT, PLEASE CALL OR SEND A WHATSAPP TO PHONE

+56 9 4508 9405

( Speak with Andrea, the secretary)

My book has crossed boundaries.

Presentation of the book and Discussion about

Dysautonomia in The Bahamas

( 115,000 visits on the first day with subtitles into 9 languages )

Folic Acid Information

Folic acid deficiency as a possible cause of hypermobile Ehlers-Danlos

DOCTOR JAIME F. BRAVO'S BOOK

I have published THE first EDITION OF MY book about

Hypermobile Ehlers-Danlos, Dysautonomia and

Fibromyalgia. the book in spanish IS available for

purchase at the doctor´s practice (+569 4508 9405)

The SECOND EDITION in spanish, that includes a chapter about

the importance of FOLIC ACID, is available for International

purchases by clicking here

ENGLISH VERSION OF THE SECOND EDITION IS NOW AVAILABLE HERE DIRECTLY FROM THE PUBLISHER

OR HERE, IN AMAZON BOOKS

My great friend and colleague, Professor Doctor Rodney Grahame, the greatest exponent on the subject of Ehlers-Danlos worldwide, congratulated me from London, England. He sent me greetings and he wrote the following regarding the book´s launch : " Dear Jaime, I hope you are doing well. Thank you for sending me a copy of your wonderful new book and your additional research. Given my current medical condition, I would be very interested in learning more about the benefits of folic acid and its impact on EDS and osteoporosis. . UNTIL NEXT TIME"

Antonio Bulbena, Professor of Psychiatry and Head of the Psychiatry Department at the Autonomous University of Barcelona.

Thanks Jaime!!!! Learning from teachers like you and from shrewd and

simple patients is my illusion and daily curiosity.
Receive my hug of gratitude and my congratulations on the success of

the presentation and launch of your book.

CLARIFICATION ON THE CHANGE OF NAME

I have determined not to continue using the Ehlers-Danlos type III diagnosis, but to use the new official classification of this syndrome, Hypermobile Ehlers-Danlos Syndrome, to avoid problems for my patients, especially those from other countries (Europe and North America) causing confusion in the type of diagnosis.

My clinical experience of more than 9000 patients, and in my work of 2300 patients, presented at the First International Symposium of Ehlers-Danlos, in September 2012, in Ghent, Belgium, with a confirmed diagnosis of Ehlers-Danlos, found that 51% were NOT hypermobile (Beighton Score equal to or less than 4/9) led me to use the name SED-III throughout my publications

MEDICAL CONSULTATION BY TELEMEDICINE

Links to other sites

RECENT ARTICLES

HIGHLIGHTED ARTICLES

Classic Ehlers-Danlos Syndrome

(Ehlers-Danlos Type I-II)

When to suspect Ehlers Danlos type

III

Vascular Ehlers-Danlos Syndrome

(EDS Type IV)

PLEASE, WHEN SENDING EMAILS, INCLUDE CITY AND COUNTRY OF ORIGIN

RECOMMENDED ARTICLES

DYSAUTONOMIA

JOINT HYPERMOBILITY:

Fibromyalgia in the 21st Century

Fibromyalgia and the Ehlers-Danlos Syndrome

Professor Jaime F. Bravo, MD

Rheumatology Joint Hipermobility / Ehlers-Danlos Syndrome Osteoporosis Dysautonomia Fibromyalgia

Professor of Medicine, Universidad de Chile, Santiago, Chile

Rheumatology Departament, San Juan de Dios Hospital, Santiago, Chile

Emeritus Professor of Medicine, University of Colorado Medical Center, Denver, CO, USA.

What is hypermobility?

Having excess mobility without symptoms is a good condition, which gives agility at any age. This is called joint hypermobility (HA). If the person has symptoms HA becomes a disease which is called Joint Hypermobility Syndrome (JHS). Symptoms include musculoskeletal (pain, sprains, subluxations, osteoarthritis or osteoporosis early, etc..) Or extra-skeletal muscle tissues as weak (hernias, disc disease, cysts, varices, dysautonomia, depression, anxiety, etc..). It is also important to know that this disease is genetic, also called Ehlers-Danlos syndrome type III, is both hypermobile and in non lax. (read more…)

Dysautonomia

What used to be called neurasthenia (inability to function due to fatigue), now called dysautonomia. Dysautonomia is a disorder of autonomic nervous system (sympathetic-vagal imbalance), which is automatically regulating many important functions in the body such as pulse, blood pressure, temperature and respiration. Controls the response of “fight or start”, as in the case of an attack, the normal response is tachycardia (pulse lifting), blood pressure (BP) and strength, but the answer is Dysautonomia inadequate and bradycardia (low pulse), fall in BP and decreased strength, fatigue and drowsiness. ( read more…)

Osteoporosis

Bones are in constant turnover, with formation and resorption. Osteoporosis is characterized by an imbalance between production and resorption, resulting in bone loss and fractures. There are multiple causes, the most frequent menopausal hormone deficiency. Something little known is the presence of Osteoporosis in Joint Hypermobility Syndrome (affects 15% of men and women under 30 years).

Folic Acid

Folic acid is a vitamin B complex (vitamin B-9) that participates in the synthesis of amino acids and thus the DNA. Prevents birth defects in children (spina bifida), abortions and infertility. There are studies that show that helps improve bone matrix and we think that probably helps in the treatment of joint hypermobility.

Recent Articles

Folic Acid Information

Fibromyalgia in the 21st Century

Fibromyalgia and the Ehlers-Danlos Syndrome

Updated, interesting and highlighted new texts

For patients, parents or tutors, teachers and physicians

Thoughts about Ehlers-Danlos and Dysautonomia

Information on hypermobility (Ehlers-Danlos) and Dysautonomia,

for parents and professors

Formative Course

Formative Course for health professionals about the Ehlers-Danlos Syndrome, held at the University of París-Est-Créteil, France

For more information, Click here.

Invitation

Prof. Bravo is a member of an International Group of 83 physicians from 14 countries, all with different specialization areas, but all interested in the Ehlers-Danlos Syndrome. Their objective is to update and/or reclassify the diagnostic criteria and treatment of the different Ehlers-Danlos Syndromes. During the year, ...

Participation in Medical Congresses

II Escuela Internacional ANSEDH

Síndromes de Ehlers-Danlos

Málaga, Spain, November 9th and 10th, 2018.

Faculty members of the congress Prof. Bulbena, Carolina Baeza-Velasco and

Prof. Hamonet. Prof. Grahame and Prof. Bravo were exposing at the time.

Prof. Bravo presented a paper about the Diagnosis and Treatment

of Dysautonomias in EhlersDanlos.

IV Ehlers-Danlos Syndrome International Colloqium

Paris, France, March 17th, 2018

Professors Bravo, Hamonet (Fr), Grahame (UK) and Amoretti (Fr)

Quite a good turn out!!!!

Prof. Bravo participated in the IV International Ehlers-Danlos Syndrome Colloquium, held in Paris. He presented a poster that comprised 2300 EDS patients, of which, using the new 2017 EDS INTERNATIONAL Criteria, 63% were not hypermobile.

1st INTERNATIONAL SCHOOL ABOUT THE EHLERS-DANLOS SYNDROMES AND HIPERMOBILITY

MURCIA, SPAIN, OCTOBER 27 AND 28, 2017

Professors Bulbena, Bravo, Baeza-Velasco, Hamonet, Henderson and Grahame

Professor Bravo dictated a practical class on the Diagnosis of the Ehlers-Danlos Syndrome.

III Ehlers-Danlos Syndrome International Colloqium

Paris, France, March 24th-25th, 2017

III Colloque Syndrome d'Ehlers-Danlos, Paris, France, 24 et 25 Mars 2017

Tour Eiffel Iluminated. Prof. Jaime Bravo presenting a poster of his work.

For the third consecutive year, Prof. Bravo was invited to participate in the III Ehlers-Danlos International Colloquium, held once again in Paris. On March the 24th, he coordinated the pre-Colloquium round table, and on the following day he participated in the Meeting and presented a poster showing his theory about the visual signs that permit to suspect the early diagnosis of EDS-III ...

American College of Rheumatology

Washington D.C., USA. November 12 -16, 2016.

Hipermobility Study Group, 2016

Prof. Bravo participated in the ACRs 2016 Annual Meeting held in Washington D.C. Once again the Joint Hypermobility Study Group came together, and Dr. Bravo, alongside Dr. Gall, were co-convenors. In this opportunity ......

II International Congress

Ehlers-Danlos and Hypermobility Syndrome

Barcelona Spain, October 7th and 8th, 2016

Dña. Josefa Lopez. Presidenta Asociación del Síndrome de Ehlers-Danlos e Hiperlaxitud (ANSEDH)

Inaugural table of the Congress, presided by Mrs. Josefa Lopez.

President of the Ehlers - Danlos and Hypermobility Syndrome Association (ANSEDH)

Recently, Prof. Bravo participated in the II International Congress about Ehlers - Danlos and Hypermobility, held in Barcelona, Spain. This time he presented a speech about the Examining a Joint Hypermobility Patient ...

Ehlers-Danlos Syndrome International Colloquium

Paris, France, March 19th, 2016

Colloque Syndrome d'Ehlers-Danlos, Paris, France, March 19th 2016.

Marco Castori Carolina Baeza-Velasco Jaime Bravo

Notre Dame, Paris, France

Prof. Bravo was invited to participate in the second Ehlers-Danlos Syndrome International Colloquium held at the Creteil University in Paris, France. In this opportunity he presented a poster explaining his Visual Aids for a better Diagnose of the Ehlers-Danlos type III Syndrome, where with the help of the pictures he has gathered during the last 17 years of study, he shows how vital the visual aid can be ... ....

Interesting summary of the Colloquium can be seen in the following video (in French)

to see old news click here

Previous Photos of the Month click here

Private Office

Dr. Bravo serves in his private office on Monday, Tuesday, and Thursday afternoons, and Friday mornings. Given his concern about Joint Hypermobility Syndrome and early diagnosis, Dr. Bravo now also sees hypermobile children from 5 years old.

For an appointment or questions click here